NSEUpdates10 Sept 2026 · 10 Sept 2026, 04:02 pm
Updates
Nureca Limited · NURECA
✦ AI SummaryRelated Party
Nureca Limited has made a disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding a designated person acquiring/purchasing shares of the company.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)'.
Attachments (1)
📄pdf
Download →
NURECA_10092026160202_StockExchnageIntimationFormCSMG10092026Signed.pdf
View document text
www.nureca.com
Dated: September 10, 2026
BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Corporate Relations Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1
Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E)
Mumbai-400001 Mumbai-400051
Scrip code: 543264 Scrip Code: NURECA
Subject: Disclosure under Regulation 7(2) of Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”)
Dear Sir/Madam,
This is to inform you that a designated person of the Company has acquired/purchased
shares of the Company and, being a designated person, the transaction is covered under
Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, read
with the applicable provisions relating to automation of continual disclosures/system-
driven disclosures under the said Regulations.
Pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of
Insider Trading) Regulations, 2015, we hereby submit the disclosure received from Ms.
Smita Goyal, a member of the Promoter Group of Nureca Limited, in the prescribed
Form C, in respect of the transaction in the securities of the Company.
Kindly take the same on record.
Thanking you,
For Nureca Limited
Nishu Kansal
Company Secretary & Compliance Officer
M. No.: A33372
NURECA LIMITED
Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009
Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS,
Andheri West, Mumbai – 400053
Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868